Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

PACB – Pacific Biosciences of California, Inc.

Float Short %

15.84

Margin Of Safety %

Put/Call OI Ratio

0.29

EPS Next Q Diff

-0.01

EPS Last/This Y

0.57

EPS This/Next Y

0.07

Price

1.38

Target Price

2

Analyst Recom

2.31

Performance Q

46.57

Relative Volume

0.78

Beta

1.88

Ticker: PACB




21 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-07-25PACB1.5350.310.0992858
2025-07-28PACB1.6450.310.0593089
2025-07-29PACB1.550.310.6993458
2025-07-30PACB1.490.310.3193654
2025-07-31PACB1.3750.310.8193711
2025-08-01PACB1.320.320.0395909
2025-08-04PACB1.40.320.0597137
2025-08-05PACB1.4150.310.1397601
2025-08-06PACB1.3850.310.0397923
2025-08-07PACB1.2650.310.1898140
2025-08-08PACB1.350.310.6898590
2025-08-11PACB1.2550.290.1999202
2025-08-12PACB1.2050.290.0799642
2025-08-13PACB1.2950.290.07100151
2025-08-14PACB1.2250.290.19100470
2025-08-15PACB1.3050.290.08100991
2025-08-18PACB1.3350.290.2096440
2025-08-19PACB1.3050.290.0296843
2025-08-20PACB1.280.290.4197362
2025-08-21PACB1.2650.290.0397621
2025-08-22PACB1.3850.290.0298513
DateSymbolLastP/C OIP/C VolTotal OI
21 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-07-25PACB1.5417.5266.3-0.64
2025-07-28PACB1.6517.2249.5-0.64
2025-07-29PACB1.5417.2279.0-0.64
2025-07-30PACB1.4917.2273.5-0.64
2025-07-31PACB1.3817.2281.2-0.64
2025-08-01PACB1.3317.2272.5-0.64
2025-08-04PACB1.3917.2256.5-0.64
2025-08-05PACB1.4217.2261.2-0.64
2025-08-06PACB1.3817.2270.7-0.64
2025-08-07PACB1.2617.2283.4-0.64
2025-08-08PACB1.3517.2251.6-0.64
2025-08-11PACB1.2517.2293.9-0.64
2025-08-12PACB1.208.7144.9-0.64
2025-08-13PACB1.288.7144.3-0.64
2025-08-14PACB1.238.7162.3-0.64
2025-08-15PACB1.308.7143.7-0.56
2025-08-18PACB1.3416.3151.0-0.56
2025-08-19PACB1.3016.3158.7-0.56
2025-08-20PACB1.2716.3158.0-0.56
2025-08-21PACB1.2616.3155.9-0.56
2025-08-22PACB1.3816.3136.7-0.56
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-07-25PACB-1.13-12.8116.80
2025-07-28PACB-1.13-13.0016.80
2025-07-29PACB-1.13-13.0016.80
2025-07-30PACB-1.13-13.0016.80
2025-07-31PACB-1.13-13.0016.80
2025-08-01PACB-1.13-13.0016.80
2025-08-04PACB-1.13-21.8616.80
2025-08-05PACB-1.13-21.8616.80
2025-08-06PACB-1.13-21.8616.80
2025-08-07PACB-1.13-21.8616.80
2025-08-08PACB-1.13-21.8616.80
2025-08-11PACB-1.13-22.0116.79
2025-08-12PACB-1.13-22.0115.84
2025-08-13PACB-1.13-22.0115.84
2025-08-14PACB-1.13-22.0115.84
2025-08-15PACB-1.13-22.0115.84
2025-08-18PACB-1.13-21.9215.84
2025-08-19PACB-1.13-21.9215.84
2025-08-20PACB-0.15-21.9215.84
2025-08-21PACB-0.15-21.9215.84
2025-08-22PACB-0.15-21.9215.84
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS

-0.13

Avg. EPS Est. Current Quarter

-0.14

Avg. EPS Est. Next Quarter

-0.14

Insider Transactions

-0.15

Institutional Transactions

-21.92

Beta

1.88

Average Sales Estimate Current Quarter

40

Average Sales Estimate Next Quarter

43

Fair Value

Quality Score

18

Growth Score

38

Sentiment Score

35

Actual DrawDown %

97.4

Max Drawdown 5-Year %

-98.2

Target Price

2

P/E

Forward P/E

PEG

P/S

2.66

P/B

6.74

P/Free Cash Flow

EPS

-2.27

Average EPS Est. Cur. Y​

-0.56

EPS Next Y. (Est.)

-0.49

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-336.4

Relative Volume

0.78

Return on Equity vs Sector %

-880.7

Return on Equity vs Industry %

-874.7

EPS 1 7Days Diff

0.1

EPS 1 30Days Diff

0.07

EBIT Estimation

136.7
Pacific Biosciences of Californ
Sector: Healthcare
Industry: Medical Devices
Employees: 575
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solution to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) technology; long-read sequencing; and various reagent kits designed for specific workflow, such as preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprise reagents required for on-instrument, real-time sequencing, including the phospholinked nucleotides. In addition, the company provides Revio, Vega, Sequel, Sequel II, and Sequel IIe instruments which conduct, monitor, and analyze single-molecule biochemical reactions in real time; SBB short-read sequencing; onso instrument conducts, monitors, and analyzes SBB biochemical reactions; and SBB consumable, including flow cells, clustering, and sequencing reagent kits. It serves academic and governmental research institutions; commercial testing and service laboratories; genome centers; public health labs, hospitals and clinical research institutes, and contract research organizations; pharmaceutical companies; and agricultural companies. The company markets its products through a sales force and distribution partners in Australia, certain parts of Asia, Europe, the Middle East, Africa, Central America, and South America. The company was formerly known as Nanofluidics, Inc. and changed its name to Pacific Biosciences of California, Inc. in 2005. Pacific Biosciences of California, Inc. was incorporated in 2000 and is headquartered in Menlo Park, California.
stock quote shares PACB – Pacific Biosciences of California, Inc. Stock Price stock today
news today PACB – Pacific Biosciences of California, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch PACB – Pacific Biosciences of California, Inc. yahoo finance google finance
stock history PACB – Pacific Biosciences of California, Inc. invest stock market
stock prices PACB premarket after hours
ticker PACB fair value insiders trading